Similarly, NAFLD fibrosis score was investigated for predicting advanced fibrosis using age, hyperglycemia, BMI, platelet count, albumin and aspartate aminotransferase (AST)/ ALT ratio (positive predictive value: 82%, negative predictive value: 93%). 13 Several inflammatory mediators are increased in NASH compared to simple hepatic steatosis such as tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), CC-chemokine ligand 2 (CCL-2), and hyaluronic acid. [14] [15] [16] Deregulation of hepatocyte apoptosis is an important mechanism of liver injury and NASH development. [17] [18] [19] Fas has a critical role in apoptosis pathway as a death receptor member of the TNF receptor family. Expression of this membrane protein is increased in NASH patients. 17 Accumulation of free fatty acids in hepatocytes results in up-regulation of Fas in the cell membrane which increases the sensitivity to Fas mediated apoptosis. 20 At the level of mitochondria, apoptosis pathway induces permiabilization of the mitochondrial outer membrane and release of multiple protein from the mitochondrial inner membrane space to cytoplasm. 21 This results in activation of effector caspases (mainly caspase 3) which will cleave substrates in cytoplasm like cytokeratin 18 (CK-18), the major intermediate filament protein of liver, inducing the specific morphologic change of apoptosis. 21 There are several reports showing that the quantification of this caspase generated CK-18 fragments is useful for diagnosis of NASH. [22] [23] [24] [25] In subject study, they investigated the apoptosis panel for non-invasive diagnosis of NASH using these two biomarkers, Further studies are needed to validate the accuracy of this apoptosis panel for NASH diagnosis in each race and country.
We need to investigate whether this apoptosis panel could be used for assessment of treatment response and predicting prognosis of NASH.
